COVID-19: CRS4 makes available to the scientific community the core facility massive sequencing for studies on SARS-CoV-2

The CRS4 (Research, Development, Higher Studies Center in Sardinia) for 30 years active in the field of research on enabling digital technologies and in particular on Biosciences, opens to international collaboration with partners who want to test the use of genomic sequencing, bioinformatics and data analysis technologies. The machines of the NEXT massive sequencing facility ( located in the Technology Park of Pula (Cagliari), will be made available to researchers from all over the world who will have the opportunity to request access remotely with a priority procedure – i.e. without having to physically move to the Pula laboratories – to carry out experiments useful for studying and developing new diagnostic methodologies, new therapies, carrying out sequence studies to support the development of vaccines, identifying the best treatments for the treatment of the disease, supporting epidemiological
monitoring useful for modulating the impact of public health interventions, using massive sequencing technologies on samples of non-pathogenic nucleic acids. The call is highlighted in the homepage of the NEXT Laboratory ( or available here.